Respiratory Medicine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Heterogeneity in Severe Asthma
2020
-
Practical considerations in the management of eosinophilic asthma
2019
-
Validation of an Electronic Version of the Mini Asthma Quality of Life Questionnaire
2009
-
Balance measures for fall risk screening in community-dwelling older adults with COPD: A longitudinal analysis.
230:107681-107681.
2024
-
Implementation of virtual pulmonary rehabilitation during the COVID-19 pandemic: Experiences and perceptions of patients and healthcare providers.
225:107588-107588.
2024
-
Corrigendum to “Burden of chronic cough on social participation, healthcare resource utilisation and activities of daily living in the Canadian Longitudinal Study on Aging (CLSA)” [Respir. Med. 219 (2013) 107431].
223:107556-107556.
2024
-
Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
222:107515-107515.
2024
-
Characteristics and risk factors of interstitial pneumonia with autoimmune features.
221:107500-107500.
2024
-
Burden of chronic cough on social participation, healthcare resource utilisation and activities of daily living in the Canadian Longitudinal Study on Aging (CLSA).
219:107431-107431.
2023
-
Home high flow nasal cannula for chronic hypercapnic respiratory failure in COPD: A systematic review and meta-analysis.
219:107420-107420.
2023
-
Comparing bronchial thermoplasty with biologicals for severe asthma: Systematic review and network meta-analysis.
216:107302-107302.
2023
-
Does peak expiratory flow moderate trajectories of cognitive function among individuals with lung diseases? A longitudinal analysis of the National Health and Aging Trends Study.
207:107120-107120.
2023
-
Responsiveness of the late life disability instrument to pulmonary rehabilitation in people with COPD.
207:107113-107113.
2023
-
Construct validity and reliability of the Informal Caregiver Burden Assessment Questionnaire (QASCI) in caregivers of patients with COPD.
205:107027-107027.
2022
-
Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: A single-centered, retrospective, observational study.
202:106982-106982.
2022
-
A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm.
201:106568-106568.
2022
-
Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
200:106917-106917.
2022
-
Occupational therapy in pulmonary rehabilitation programs: A scoping review.
199:106881-106881.
2022
-
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
200:106863-106863.
2022
-
Association of BMI with pulmonary function, functional capacity, symptoms, and quality of life in ILD.
195:106792-106792.
2022
-
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study.
191:106722-106722.
2022
-
Rapid access rehabilitation after exacerbations of COPD – A qualitative study.
186:106532-106532.
2021
-
Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study.
180:106368-106368.
2021
-
A comprehensive analysis of factors related to lung function in older adults: Cross-sectional findings from the Canadian Longitudinal Study on Aging.
173:106157-106157.
2020
-
Randomized controlled trial of community-based, post-rehabilitation exercise in COPD.
174:106195-106195.
2020
-
Sputum quantitative cytometry in patients with interstitial lung disease and chronic cough.
170:106067-106067.
2020
-
Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanib.
156:20-25.
2019
-
Effects of exercise training on cognition in chronic obstructive pulmonary disease: A systematic review.
139:110-116.
2018
-
Sputum plug selection under inverted microscopy improves microbial identification during exacerbations of airway diseases.
134:92-94.
2018
-
Therapeutic targets in idiopathic pulmonary fibrosis.
131:49-57.
2017
-
Informal caregiving in COPD: A systematic review of instruments and their measurement properties.
128:13-27.
2017
-
Systemic inflammation and lung function: A longitudinal analysis.
111:54-59.
2016
-
Corrigendum to “Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial” [Res Med 108 (2014) 41–49].
109:146-146.
2015
-
Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis.
108:1023-1030.
2014
-
Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.
108:181-188.
2014
-
Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial.
108:41-49.
2014
-
A novel approach to long-term respiratory care: Results of a community-based post-rehabilitation maintenance program in COPD.
107:1210-1216.
2013
-
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.
107:656-664.
2013
-
Comparison of changes in lung function measured by plethymography and IOS after bronchoprovocation.
107:503-510.
2013
-
A simple method to derive speed for the endurance shuttle walk test.
106:1665-1670.
2012
-
Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.
106:1487-1493.
2012
-
Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects.
106:1139-1147.
2012
-
Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
105:1836-1845.
2011
-
Lipid and smoker’s inclusions in sputum macrophages in patients with airway diseases.
105:1691-1695.
2011
-
Expiratory flows and airway inflammation in elderly asthmatic patients.
105:1284-1289.
2011
-
Validation of an electronic version of the Mini Asthma Quality of Life Questionnaire.
104:658-667.
2010
-
A simple and portable breathing circuit designed for ventilatory muscle endurance training (VMET).
103:1822-1827.
2009
-
Impairments in balance discriminate fallers from non-fallers in COPD.
103:1885-1891.
2009
-
Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials.
103:1960-1968.
2009
-
Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
103:1623-1632.
2009
-
Response to the Letter to the Editor.
103:1240-1241.
2009
-
Safety, pharmacodynamics and pharmacokinetics of TPI 1020 in smokers with asthma.
103:1159-1166.
2009
-
Patients may respond differently to paper and electronic versions of the same questionnaires.
103:932-934.
2009
-
Duration of pulmonary rehabilitation to achieve a plateau in quality of life and walk test in COPD.
103:722-728.
2009
-
Inspiratory muscle training in adults with chronic obstructive pulmonary disease: An update of a systematic review.
102:1715-1729.
2008
-
Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma.
102:77-81.
2008
-
Changing pattern of sputum cell counts during successive exacerbations of airway disease.
101:2217-2220.
2007
-
Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease.
101:308-316.
2007
-
Self-care approaches to managing chronic obstructive pulmonary disease: A provincial survey.
100:1540-1546.
2006
-
Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire.
100:616-621.
2006
-
Inspiratory muscle training in adults with chronic obstructive pulmonary disease: A systematic review.
99:1440-1458.
2005
-
Once-daily ciclesonide 80 or 320μg for 12 weeks is safe and effective in patients with persistent asthma.
99:1275-1285.
2005
-
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire.
99:553-558.
2005
-
Past, present and future—β2-adrenoceptor agonists in asthma management.
99:152-170.
2005
-
Measurement of agreement on health-related quality of life changes in response to respiratory rehabilitation by patients and physicians—A prospective study.
98:1195-1202.
2004
-
An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma.
98:1146-1154.
2004
-
Self-administration and standardisation of the chronic respiratory questionnaire: a randomised trial in three German-speaking countries.
98:342-350.
2004
-
Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
97:242-249.
2003
-
Decision-making by healthcare payers.
96:S31-S38.
2002
-
The evolution of β2-agonists.
95:S2-S6.
2001
-
Adding formoterol to budesonide in moderate asthma—health economic results from the FACET study.
95:505-512.
2001
-
Measuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use?.
95:319-323.
2001
-
Amiodarone and the lung: wide variations in clinical practice.
94:1130-1131.
2000
-
Acute effects of nebulised epoprostenol in pulmonary hypertension due to systemic sclerosis.
93:75-78.
1999
-
Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhaler.
87:609-620.
1993
-
The effect of increasing doses of β-agonists on airflow in patients with chronic airflow limitation.
87:433-438.
1993
-
Measuring functional status in chronic lung disease:conclusions from a randomized control trial.
85:17-21.
1991
-
Measuring functional status in chronic lung disease: conclusions from a randomized control trial.
83:293-297.
1989
-
Childhood asthma in New Zealand.
81:332-340.
1987
-
Quality of life in patients with chronic airflow limitation.
81:45-54.
1987
-
Interpretation of blood gas analysis by physicians in a community teaching hospital.
73:237-242.
1979
-
Small-cell lung cancer: A curable disease?.
73:327-348.
1979
-
Exercise testing.
61:169-189.
1967
has subject area
Identity
International Standard Serial Number (ISSN)
-
0007-0971
-
0954-6111
-
1073-449X
Electronic International Standard Serial Number (EISSN)